In the ever-evolving landscape of healthcare, podiatry has witnessed a transformative change over the last decade, thanks in no small part to the strategic vision and leadership of Dr. David Freedman, Vice-President of Foot and Ankle Specialists of the Mid-Atlantic, LLC (FASMA). Under his guidance as a major player on the executive team, FASMA has not only navigated the waters of change but has also set a new standard for what a podiatric practice can achieve through innovation, collaboration, and strategic partnerships.
A Vision for Growth and Excellence
Dr. Freedman’s journey in the podiatric field is marked by a relentless pursuit of excellence and an unwavering commitment to patient care. As a board-certified foot surgeon, a Fellow in both the American College of Foot and Ankle Surgeons and the American Society of Podiatric Surgeons, and with extensive experience in medical coding and auditing, Dr. Freedman brought a wealth of knowledge and a unique perspective to FASMA. His leadership has been instrumental in shaping the organization’s strategic direction, focusing on growth through quality care and operational efficiency.
Embracing Change with Private Equity
One of the pivotal moments in FASMA’s history was its decision to embrace private equity in 2018, a move that has fueled its expansion and solidified its position as the largest podiatric professional group in the country. With over 250 podiatrists across 175 locations in 20 states, FASMA evolved into USFAS, which has set a new benchmark for scale in the podiatry field. This strategic partnership has enabled USFAS to leverage financial resources and business acumen to optimize operations, invest in technology, and expand its footprint, all while maintaining a laser focus on patient care and clinical excellence.
The Impact of Strategic Growth
The growth of FASMA under Dr. Freedman’s leadership and through its partnership with private equity, creating USFAS, has had a profound impact on the podiatric profession. It has demonstrated the viability and benefits of scaling operations in a specialty medical field, providing a model for others to follow. This expansion has not only improved access to high-quality foot and ankle care for patients across the United States but has also created opportunities for podiatrists to join a dynamic and forward-thinking organization that values clinical excellence and professional development.
Looking to the Future
As USFAS continues to grow and evolve, the organization remains committed to its core mission of delivering exceptional podiatric care. USFAS is well-positioned to navigate the challenges and opportunities that lie ahead in the healthcare landscape. The organization’s strategic use of private equity, combined with its focus on clinical excellence and operational efficiency, will continue to serve as a foundation for its success.
How Telehealth is Transforming the Skincare Industry(Opens in a new browser tab)
A Legacy of Leadership and Innovation
Dr. David Freedman’s leadership and vision have not only transformed FASMA into its current entity, USFAS, but have also made a lasting impact on the podiatric profession. By embracing change, pursuing strategic growth, and maintaining a steadfast commitment to patient care, USFAS has set a new standard for what is possible in podiatry. As the organization looks to the future, it does so with a strong foundation and a clear vision for continuing to lead the way in foot and ankle care.
Discussion about this post